Table 2.
Goal and target-population
| Question | Frequency |
|---|---|
| Primary purpose | |
| Diagnostic | 4/54 (7.4 %) |
| Evaluative | 46/54 (85.2 %) |
| Prognostic | 3/54 (5.6 %) |
| Else | 1/54 (1.9 %) |
| Secondary purpose(s) | |
| Yes, namely | 29/48 (60.4 %) |
| Diagnostica | 8/34 (23.5 %) |
| Evaluativea | 6/34 (17.6 %) |
| Prognostica | 23/34 (67.6 %) |
| Elsea | 5/34 (14.7 %) |
| No | 19/48 (39.6 %) |
| Primary population | |
| Cerebral Palsy | 53/53 (100 %) |
| Else (e.g. Developmental Coordination Disorder, Neuromuscular disorders, Acquired brain impairment, Rheumatic disorders, Spina Bifida or Down Syndrome) | 0/53 (0.0 %) |
| Secondary population(s) | |
| Yes | 32/51 (62.7 %) |
| Cerebral Palsya | 1/35 (2.9 %) |
| Developmental Coordination Disordera | 0/35 (0.0 %) |
| Neuromuscular disordersa | 8/35 (22.9 %) |
| Acquired brain impairmenta | 18/35 (51.4 %) |
| Rheumatic disordersa | 1/35 (2.9 %) |
| Spina Bifidaa | 3/35 (8.6 %) |
| Down Syndromea | 13/35 (37.1 %) |
| Elsea | 10/35 (28.6 %) |
| No | 19/51 (37.3 %) |
| Primary age category | |
| < 5 months | 0/52 (0.0 %) |
| 5 months – 5 years | 19/52 (36.5 %) |
| 6–11 years | 29/52 (55.8 %) |
| 12–16 years | 4/52 (7.7 %) |
| > 16 years | 0/52 (0.0 %) |
| Secondary age category | |
| Yes | 46/50 (92.0 %) |
| < 5 monthsa | 1/50 (2.0 %) |
| 5 months – 5 yearsa | 37/50 (74.0 %) |
| 6–11 yearsa | 19/50 (38.0 %) |
| 12–16 yearsa | 24/50 (48.0 %) |
| > 16 yearsa | 12/50 (24.0 %) |
| No | 4/50 (8.0 %) |
aMultiple answers possible